PARVIZ SALEHI: Open Payments
NPI 1932124328 · RESEDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75 in 3 payments from 3 companies in 2025. Trend: 2023 $270 · 2024 $197 · 2025 $75
Food & beverage: $75
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Iovance Biotherapeutics, Inc. | 1 | $18 |
Products named: LYNPARZA, PLUVICTO, Amtagvi.
Industry payments across CA — which companies pay providers there.
